+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serotonin-related gene pathways associated with undifferentiated somatoform disorder



Serotonin-related gene pathways associated with undifferentiated somatoform disorder



Psychiatry Research 189(2): 246-250



It has been suggested that serotonergic hypofunction and serotonergic pathway genes underlie the somatic symptoms of somatoform disorders. We examined a variety of serotonin-related gene polymorphisms to determine whether undifferentiated somatoform disorder is associated with specific serotonin-related gene pathways. Serotonin-related polymorphic markers were assessed using single nucleotide polymorphism (SNP) genotyping. One hundred and two patients with undifferentiated somatoform disorder and 133 healthy subjects were enrolled. The genotype and allele frequencies of tryptophan hydroxylase (TPH)1 A218C, TPH2 rs1386494, serotonin receptor 2A-T102C (5-HTR 2A-T102C), 5-HTR 2A-G1438A and serotonin transporter (5HTTLPR) gene were compared between the groups. The Hamilton Rating Scale for Depression and the somatization subscale of the Symptom Checklist-90-Revised (SCL-90-R) were used for psychological assessment. Patients with undifferentiated somatoform disorder had higher frequencies of the TPH1 C allele than healthy controls (p=0.02) but the difference was not significant after Bonferroni correction. The frequency of TPH1 genotype also did not differ significantly between the patients and the healthy controls, nor did TPH2 rs1386494, 5-HTR 2A-T102C, 5-HTR 2A-G1438A or 5HTTLPR allele and genotype frequencies differ significantly between the two groups. These findings suggest that a variety of serotonin-related gene pathways are unlikely to be definite genetic risk factors for undifferentiated somatoform disorder. Therefore, the pathogenesis of the disorder may be related to epigenetic factors, including psychosocial and cultural factors. Nonetheless, future studies need to include a larger sample of subjects and polymorphisms of more serotonin-related gene variants.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036084673

Download citation: RISBibTeXText

PMID: 21531467

DOI: 10.1016/j.psychres.2011.04.002


Related references

Somatic symptom disorder and undifferentiated somatoform disorder, which is broader? Response to "Clinical value of DSM IV and DSM 5 criteria for diagnosing the most prevalent somatoform disorders in patients with medically unexplained physical symptoms (MUPS)". Journal of Psychosomatic Research 89: 114-115, 2016

Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder. Journal of Clinical Psychiatry 73(5): E574-E579, 2012

Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Archives of General Psychiatry 54(4): 352-358, 1997

Shared neural activity in panic disorder and undifferentiated somatoform disorder compared with healthy controls. Journal of Clinical Psychiatry 71(12): 1576-1581, 2010

Somatization disorder and undifferentiated somatoform disorder. Gabbard, G O [Author] Treatments of psychiatric disorders, Second edition, Vols 1 and 2 1717-1733, 1995

Undifferentiated somatoform disorder and biopsychosocial approach. Psiquis 24(4): 19-23, 2003

Effects of Yoku-kan-san on undifferentiated somatoform disorder with tinnitus. European Psychiatry 20(1): 74-75, 2005

Relationship between neural activity and immunity in patients with undifferentiated somatoform disorder. Psychiatry Research 202(3): 252-256, 2012

Conceptual issues in undifferentiated somatoform disorder and chronic fatigue syndrome. Current Opinion in Psychiatry 19(6): 613-618, 2006

Paroxetine for patients with undifferentiated somatoform disorder: A prospective, open-label, 8-week pilot study. Current Therapeutic Research Clinical and Experimental 69(3): 221-231, 2008

Acoustic neuroma identified after electroconvulsive therapy in a patient with recurrent major depression and undifferentiated somatoform disorder. Journal of Ect 26(4): 330-331, 2010

Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32(2): 437-444, 2008

Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial. Clinical Drug Investigation 28(4): 251-261, 2008

The concept of comorbidity in somatoform disorder--a DSM-V alternative for the DSM-IV classification of somatoform disorder. Journal of Psychosomatic Research 68(1): 97-9; Author Reply 99-100, 2010

A comparison of tricyclic antidepressant response in patients with somatoform pain disorder somatoform pain disorder with major depression and major depressive disorder. Pain (Suppl. 5): S327, 1990